Latest news and articles about الأدوية from NEX English
Studies indicate that nonsteroidal anti-inflammatory painkillers, such as ibuprofen, may raise blood pressure, increasing the risk of heart disease. Hypertension patients are advised to avoid these medications.
Mikhail Kovaltchouk, head of the National Research Center 'Kurchatov Institute', revealed the potential of using the space environment to develop new drug manufacturing techniques through 3D printing. This initiative represents a shift in how medical materials are produced.
The Governor of New Valley inaugurated the first branch of the 'Ambulance' pharmacy in Al-Kharijah, aiming to enhance healthcare services in the region. This opening is part of the government's efforts to improve healthcare quality and provide essential medicines to citizens.
Ongoing airstrikes by the United States and Israel on Iran are putting the country's healthcare system under increasing pressure. Doctors and activists warn that these attacks are depriving thousands of essential medical treatment.
Legislators in Mississippi have passed a bill criminalizing the use of abortion-inducing drugs and sent it to the governor for approval. This decision reflects the growing political trend against abortion rights in the United States.
Reports indicate that the U.S. Food and Drug Administration (FDA) intends to permit the production of 14 peptides that were previously banned due to safety concerns. This decision comes amid increasing calls for the use of these substances in medical treatments.
The Federal Authority for Medicines and Medical Products in the UAE announced the breaking of the medical product monopoly, enhancing market competition. This initiative aims to improve healthcare quality and provide affordable medications.
Pharmaceutical companies in Germany and Switzerland have warned that new US tariffs on drug products pose a serious threat to production sites in Europe, raising concerns about the future of the industry.
The British government has announced the completion of a deal with the United States that allows British drugs to enter the American market without tariffs. This move aims to strengthen trade relations between the two countries following Britain's exit from the European Union.
The Trump administration has announced new tariffs on imported drugs to boost domestic production and reduce reliance on imports. Simultaneously, it has eased tariffs on certain metals to simplify the customs system.
The U.S. Environmental Protection Agency (EPA) announced plans to classify microplastics and pharmaceuticals as contaminants in drinking water, reflecting growing concerns about water quality and human health. This decision comes amid increasing global awareness of pollution risks.
The UK government has announced a new agreement with the United States aimed at increasing drug spending in the UK. This initiative is part of efforts to attract more investments from major pharmaceutical companies.
German pharmaceutical giant Bayer has announced that it expects to generate most of its revenue from the American market following a strategic shift in its business model. This change comes as Europe faces challenges in providing affordable medications.
The Egyptian Minister of Health, Dr. Khaled Abdel Ghaffar, chaired a meeting of the Egyptian Unified Procurement Authority's Board of Directors to discuss strategies for enhancing the efficiency of the health system and ensuring the availability of medicines and medical supplies.
Eli Lilly has signed a $2 billion agreement with a biotech firm in Hong Kong to develop AI-based drugs, reflecting a growing trend among global pharmaceutical companies to seek new treatments in the Chinese market.
Thousands of displaced patients in Lebanon face severe health challenges due to war, with their suffering exacerbated by a deteriorating healthcare system and a shortage of medications. Concerns are rising over the worsening health conditions amid a lack of necessary care.
In a significant move, Tunisian President Kais Saied has authorized financial allocations for the Central Pharmacy, aiming to ensure a continuous supply of medications in the market. This decision comes as patients face a severe shortage of essential drugs.
The ongoing conflict in the Middle East is likely to lead to severe drug shortages in Europe, according to reports from the Swedish Medical Agency. This crisis could impact the health of millions across the continent.